TAS2R38 and COVID-19: In conclusion, this study, relying on a careful evaluation of COVID-19 associated symptoms and genetic analyses, allowed us to (1) exclude the role of TAS2R38 in determining COVID-19 symptom severity, (2) gain novel insights on the impact of the TAS1R3 gene on COVID-19 symptom severity and immune response.